本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aspire Biopharma Holdings Inc.

0.3838
-0.0362-8.62%
盘后0.3800-0.0038-0.99%19:59 EDT
成交量:1,840.05万
成交额:696.35万
市值:1,900.81万
市盈率:-1.01
高:0.4050
开:0.4000
低:0.3560
收:0.4200
52周最高:15.80
52周最低:0.2012
股本:4,952.60万
流通股本:3,534.56万
量比:0.12
换手率:52.06%
股息:- -
股息率:- -
每股收益(TTM):-0.3817
每股收益(LYR):-0.0030
净资产收益率:--
总资产收益率:-64.24%
市净率:-1.98
市盈率(LYR):-128.97

数据加载中...

2025/09/26

重要事件披露

Form 8-K - Current report
2025/09/26

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/09/18

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/08/22

重要事件披露

Form 8-K - Current report
2025/08/13

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2025/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/30

重要事件披露

Form 8-K - Current report
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/10

重要事件披露

Form 8-K - Current report
2025/05/28

SEC问询函

Form CORRESP - Correspondence
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/13

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/04/30

重要事件披露

Form 8-K - Current report
2025/04/19

SEC问询函

Form CORRESP - Correspondence
2025/04/18

重要事件披露

Form 8-K - Current report
2025/04/09

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/04/07

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/21

重要事件披露

Form 8-K - Current report
2025/02/20

重要事件披露

Form 8-K - Current report
2025/02/19

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities